Caldwell Trust CO Gilead Sciences, Inc. Transaction History

Caldwell Trust CO

  • $1.07 Trillion
  • Q3 2025

A detailed history of Caldwell Trust CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Caldwell Trust CO holds 1,093 shares of GILD stock, worth $136,646. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,093
Previous 1,093 -0.0%
Holding current value
$136,646
Previous $121 Million 0.12%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Sep 22, 2025
BUY
$96.91 - $113.0 $105,922 - $123,509
1,093 New
1,093 $121 Million
Q1 2025

Sep 23, 2025
BUY
$89.14 - $117.41 $4,546 - $5,987
51 Added 4.67%
1,144 $128 Million
Q4 2024

Sep 24, 2025
SELL
$83.95 - $97.9 $18,552 - $21,635
-221 Reduced 19.75%
898 $82.9 Million
Q3 2024

Sep 24, 2025
BUY
$66.59 - $83.99 $10,055 - $12,682
151 Added 15.6%
1,119 $93.8 Million
Q2 2024

Sep 24, 2025
SELL
$63.15 - $72.88 $7,893 - $9,110
-125 Reduced 11.44%
968 $66.4 Million
Q4 2023

Oct 01, 2025
SELL
$73.27 - $83.09 $13,628 - $15,454
-186 Reduced 14.54%
1,093 $88.5 Million
Q3 2023

Oct 01, 2025
SELL
$73.94 - $80.67 $7,394 - $8,067
-100 Reduced 7.25%
1,279 $95.8 Million
Q2 2023

Oct 01, 2025
BUY
$76.01 - $86.7 $2,888 - $3,294
38 Added 2.83%
1,379 $106 Million
Q1 2023

Oct 01, 2025
BUY
$77.31 - $88.08 $19,172 - $21,843
248 Added 22.69%
1,341 $111 Million
Q4 2022

Oct 01, 2025
SELL
$62.32 - $89.47 $124 - $178
-2 Reduced 0.18%
1,108 $95.1 Million
Q3 2022

Oct 01, 2025
BUY
$59.54 - $68.01 $1,012 - $1,156
17 Added 1.56%
1,110 $68.5 Million
Q2 2022

Oct 01, 2025
BUY
$57.72 - $65.01 $2,597 - $2,925
45 Added 4.21%
1,113 $68.8 Million
Q1 2022

Oct 01, 2025
SELL
$57.92 - $72.58 $1,448 - $1,814
-25 Reduced 2.29%
1,068 $63.5 Million
Q3 2021

Oct 02, 2025
SELL
$67.69 - $73.03 $23,014 - $24,830
-340 Reduced 23.32%
1,118 $78.1 Million
Q1 2021

Oct 02, 2025
BUY
$60.0 - $68.46 $21,900 - $24,987
365 Added 33.39%
1,458 $94.2 Million
Q4 2020

Oct 02, 2025
BUY
$56.65 - $64.55 $27,758 - $31,629
490 Added 44.83%
1,583 $92.2 Million
Q2 2020

Oct 02, 2025
BUY
$72.34 - $84.0 $14,468 - $16,800
200 Added 14.46%
1,583 $122 Million
Q1 2020

Oct 02, 2025
BUY
$62.63 - $80.22 $18,162 - $23,263
290 Added 26.53%
1,383 $103 Million
Q4 2019

Oct 06, 2025
BUY
$61.62 - $67.78 $22,737 - $25,010
369 Added 33.76%
1,462 $95 Million

Others Institutions Holding GILD

# of Institutions
2,378
Shares Held
1.01B
Call Options Held
10.4M
Put Options Held
8.12M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $157B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Caldwell Trust CO Portfolio

Follow Caldwell Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caldwell Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Caldwell Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email